SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,612,896 shares; 2025Q1: 5,612,896 shares; 2025Q2: 5,612,896 shares; 2025Q3: 5,612,896 shares; 2025Q4: 6,897,652 shares; 2026Q1: 6,897,652 shares; 2026Q2: 6,897,652 shares; 2026Q3: 6,897,652 shares 6,897,652 $333M 31.69% 0 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,074,916 shares; 2025Q1: 5,674,916 shares; 2025Q2: 5,674,916 shares; 2025Q3: 6,263,151 shares; 2025Q4: 5,871,018 shares; 2026Q1: 5,871,018 shares; 2026Q2: 5,871,018 shares; 2026Q3: 5,871,018 shares 5,871,018 $148M 14.03% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,768,520 shares; 2025Q1: 3,149,128 shares; 2025Q2: 3,149,128 shares; 2025Q3: 3,149,128 shares; 2025Q4: 3,149,128 shares; 2026Q1: 3,149,128 shares; 2026Q2: 3,149,128 shares; 2026Q3: 3,066,453 shares 3,066,453 $120M 11.41% -82,675 Timeline ALMR ALAMAR BIOSCIENCES INC More: the full row for ALAMAR BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,480,310 shares; 2026Q3: 2,480,310 shares 2,480,310 $84.5M 8.04% 0 Timeline SGP SPYGLASS PHARMA INC More: the full row for SPYGLASS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,109,953 shares; 2026Q2: 2,109,953 shares; 2026Q3: 2,109,953 shares 2,109,953 $54.9M 5.22% 0 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,266,498 shares; 2025Q1: 3,266,498 shares; 2025Q2: 4,801,370 shares; 2025Q3: 4,801,370 shares; 2025Q4: 5,756,984 shares; 2026Q1: 6,345,219 shares; 2026Q2: 6,345,219 shares; 2026Q3: 7,235,809 shares 7,235,809 $53.5M 5.08% +890,590 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,717,127 shares; 2025Q1: 1,717,127 shares; 2025Q2: 1,717,127 shares; 2025Q3: 1,717,127 shares; 2025Q4: 1,717,127 shares; 2026Q1: 1,717,127 shares; 2026Q2: 1,717,127 shares; 2026Q3: 1,867,127 shares 1,867,127 $51.9M 4.94% +150,000 Timeline KLRS KALARIS THERAPEUTICS INC More: the full row for KALARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 11,448,081 shares; 2025Q2: 11,448,081 shares; 2025Q3: 11,448,081 shares; 2025Q4: 12,948,081 shares; 2026Q1: 12,948,081 shares; 2026Q2: 12,881,175 shares; 2026Q3: 12,881,175 shares 12,881,175 $37.2M 3.54% 0 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,194,805 shares; 2026Q1: 5,194,805 shares; 2026Q2: 6,314,805 shares; 2026Q3: 6,314,805 shares 6,314,805 $23.3M 2.22% 0 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 556,044 shares; 2026Q3: 556,044 shares 556,044 $18M 1.71% 0 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 204,503 shares; 2026Q1: 1,062,872 shares; 2026Q2: 1,062,872 shares; 2026Q3: 1,062,872 shares 1,062,872 $17.1M 1.63% 0 Timeline PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,240,000 shares 7,240,000 $12.1M 1.15% new Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 837,173 shares 837,173 $11.5M 1.09% new Timeline AQST AQUESTIVE THERAPEUTICS INC More: the full row for AQUESTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,500,000 shares; 2025Q4: 2,500,000 shares; 2026Q1: 2,500,000 shares; 2026Q2: 2,500,000 shares; 2026Q3: 2,434,367 shares 2,434,367 $11.3M 1.07% -65,633 Timeline VTVT VTV THERAPEUTICS INC More: the full row for VTV THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 206,784 shares; 2025Q1: 206,784 shares; 2025Q2: 206,784 shares; 2025Q3: 374,461 shares; 2025Q4: 298,496 shares; 2026Q1: 298,496 shares; 2026Q2: 298,496 shares; 2026Q3: 354,730 shares 354,730 $10.9M 1.04% +56,234 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 531,163 shares; 2025Q3: 531,163 shares; 2025Q4: 968,798 shares; 2026Q1: 968,798 shares; 2026Q2: 736,237 shares; 2026Q3: 736,237 shares 736,237 $10.3M 0.98% 0 Timeline NKTX NKARTA INC More: the full row for NKARTA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,768,035 shares; 2025Q1: 3,768,035 shares; 2025Q2: 3,768,035 shares; 2025Q3: 3,768,035 shares; 2025Q4: 3,507,666 shares; 2026Q1: 3,507,666 shares; 2026Q2: 3,507,666 shares; 2026Q3: 3,507,666 shares 3,507,666 $9.19M 0.87% 0 Timeline RANI RANI THERAPEUTICS HLDGS INC More: the full row for RANI THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,500,000 shares; 2026Q1: 8,500,000 shares; 2026Q2: 10,369,159 shares; 2026Q3: 10,369,159 shares 10,369,159 $8.2M 0.78% 0 Timeline ARTV ARTIVA BIOTHERAPEUTICS INC More: the full row for ARTIVA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 291,666 shares; 2025Q1: 291,666 shares; 2025Q2: 291,666 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 954,861 shares; 2026Q3: 954,861 shares 954,861 $6.8M 0.65% 0 Timeline AGMB AGOMAB THERAPEUTICS NV More: the full row for AGOMAB THERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 594,749 shares 594,749 $6.6M 0.63% -5,251 Timeline ELOX ELOXX PHARMACEUTICALS INC More: the full row for ELOXX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 400,000 shares 400,000 $6.12M 0.58% 0 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 850,000 shares; 2025Q1: 425,000 shares; 2025Q2: not reported; 2025Q3: 75,442 shares; 2025Q4: 75,442 shares; 2026Q1: 56,581 shares; 2026Q2: 55,095 shares; 2026Q3: 55,095 shares 55,095 $5.46M 0.52% 0 Timeline CHRS COHERUS ONCOLOGY INC More: the full row for COHERUS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,428,571 shares; 2026Q2: 3,428,571 shares; 2026Q3: 3,383,565 shares 3,383,565 $4.09M 0.39% -45,006 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,960,000 shares; 2026Q1: 1,832,566 shares; 2026Q2: 1,395,587 shares; 2026Q3: 1,347,723 shares 1,347,723 $3.91M 0.37% -47,864 Timeline UPB UPSTREAM BIO INC More: the full row for UPSTREAM BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,217,146 shares; 2025Q1: 2,067,146 shares; 2025Q2: 1,443,231 shares; 2025Q3: 962,154 shares; 2025Q4: 736,047 shares; 2026Q1: 736,047 shares; 2026Q2: 353,717 shares; 2026Q3: 300,361 shares 300,361 $1.58M 0.15% -53,356 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $1.25M 0.12% new Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 87,956 shares 87,956 $1.04M 0.1% new Timeline